Physician

Elite Bor-Shavit, MD

According to 2025 Medicare claims, Elite Bor-Shavit, MD (NPI: 1104303858) practices ophthalmology in the Worcester, MA market, with the plurality of this provider's patient population coming from Worcester, MA. This provider's primary affiliated billing organization is D'AMBROSIO EYE CARE, INC. (NPI: 1922020874; TIN: 043087566) and primary practice location at 01523-3029. Bor-Shavit is affiliated with the UMASS Memorial Accountable Care Organization, INC. (ACO ID: A2598), participating under the MSSP model.

Bor-Shavit's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 678 traditional Medicare patients, billed 30,926 HCPCS/CPT codes, and received $1,766,631 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 465 prescription claims across 134 beneficiaries totaling $61,643 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 7 records totaling $733. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,061,414 to $1,766,631. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$883K$1.8M2019 Medicare payment: $1,061,414 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,112,048 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,283,497 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,356,574 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,615,397 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,766,631 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20195924,829$1,061,414
20205985,225$1,112,048
20216946,895$1,283,497
20226867,871$1,356,574
202364121,270$1,615,397
202467830,926$1,766,631

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$38K$76K2018 Drug cost: $491 (USD; Tot_Drug_Cst)2019 Drug cost: $20,825 (USD; Tot_Drug_Cst)2020 Drug cost: $76,229 (USD; Tot_Drug_Cst)2021 Drug cost: $69,274 (USD; Tot_Drug_Cst)2022 Drug cost: $56,152 (USD; Tot_Drug_Cst)2023 Drug cost: $65,375 (USD; Tot_Drug_Cst)2024 Drug cost: $61,643 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R16$491
201988241$20,825
2020131367$76,229
2021127459$69,274
2022114363$56,152
2023119414$65,375
2024134465$61,643

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more525586$94
67028Injection of drug into eye1931,013$87
92134Imaging of retina6311,607$31
92250Photography of the retina220294$28
92201Extended exam of the back part of the eye with retinal drawing381398$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine251,830$37,198
DifluprednateDifluprednate871,986$7,794
CyclosporineCyclosporine12840$4,147
Prednisolone AcetatePrednisolone Acetate582,106$2,262
MoxifloxacinMoxifloxacin Hcl891,431$1,403

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$733Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elite Bor-Shavit, MD?

Tedicare shows public-source Medicare data for Elite Bor-Shavit, MD (NPI 1104303858), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elite Bor-Shavit, MD have ACO affiliation data?

Elite Bor-Shavit, MD is shown with ACO affiliation data for UMASS Memorial Accountable Care Organization, INC. (MSSP, ACO ID A2598).

What billing organization is linked to Elite Bor-Shavit, MD?

Elite Bor-Shavit, MD is linked to D'AMBROSIO EYE CARE, INC. (billing NPI 1922020874) in the available physician profile data.

Does Elite Bor-Shavit, MD have Open Payments data?

Elite Bor-Shavit, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.